Resource

 

 

 

 

 

 

 

 

 

 

 

M&A: Seller's Counsel

BTG Pactual completes sale of BSI SA to EFG International

03 Nov 2016

On November 1, 2016, Banco BTG Pactual S.A. (BTG Pactual) and EFG International AG (EFGI), the listed Swiss private wealth manager, announced the completion of the sale and purchase of all the shares of BSI SA, a Swiss private bank with headquarters in Lugano. As a result of the transaction, BTG Pactual has become a significant shareholder of EFGI with an interest of 30% of the share capital and voting rights of EFGI, which is now one of the largest Swiss private banks.

DWF advises Blue Chip Holidays’ shareholders through acquisition

03 Nov 2016

DWF has advised the shareholders of cottage and luxury lodge business Blue Chip Holidays on its acquisition by Wyndham Vacation Rentals UK (WVR UK) as part of a strategic plan to develop its national self-catering portfolio.
 
The acquisition will enable Blue Chip Holidays to build on its rapid growth across the South West with a vision to expand further nationally. The company will continue to operate as usual and managing director Allan Lambert remains in place following the deal, which completed today.
 

Gide on the sale to TUI of the French and Greek activities of Canadian tour operator Transat

02 Nov 2016

Gide has advised Transat A.T. inc., a Canadian group listed on the Toronto stock exchange and that specialises in various tourism and travel activities, on the sale to group TUI, the world’s leading tourism group, of its tour operator activities in France (Transat France includes brands Look Voyages and Vacances Transat) and in Greece (TourGreece).

McDermott acted as counsel to TUI.

The deal was authorised by the European Commission as regards merger control, and was finalised on 31 October 2016.

Reed Smith advises Target Partners on the sale of 1-2-3.tv

01 Nov 2016

Reed Smith has advised Target Partners on all aspects of the sale of its shares in 1-2-3.tv GmbH, the operator of the first German auction channel, to ARCUS Capital AG (ARCUS) and BE Beteiligungen Fonds GmbH & Co. KG. The terms of the acquisition were not disclosed. The transaction is subject to regulatory approval and is expected to close before the year end.

Astellas Pharma buys Ganymed Pharmaceuticals

01 Nov 2016

Baker & McKenzie advised the owners of Ganymed Pharmaceuticals AG ("Ganymed"), a pharmaceutical company based in Mainz, in the sale to Japanese Astellas Pharma, Inc. ("Astellas").

Astellas takes over Ganymed for 422 million euros. The majority shareholder of Ganymed is the ATS Beteiligungsverwaltung, the other shareholders are MIG funds, Future Capital AG, FCPB Gany GmbH and private investors. The purchase price could increase to more than 1.2 billion euros through additional performance-based  milestone payments of up to 860 million euros.

C4 Shopping Holding divests C4 Shopping in Kristianstad to Dutch shopping centre giant Eurocommercial Properties

01 Nov 2016

Eurocommercial aquires C4 Shopping, under construction in Kristianstad. C4 Shopping, which includes a total of approximately 40,000 square meters, is expected to be completed by the end of 2018. The shopping centre is located next to the E22 road and is planed to accommodate 90 stores and restaurants. A 6.500 square meter supermarket will be built opposite from the centre. The transaction value of the site of commerce, also including a volume retail area, amounts to approximately SEK 1.7 billion.

Bär & Karrer Advises Auven Therapeutics on Sale of Ocular Technologies to Sun Pharmaceutical Industries

31 Oct 2016

Auven Therapeutics, an international private equity company focused on accelerated development of therapeutic drugs, has signed an agreement to sell its Swiss subsidiary Ocular Technologies Sarl, to India-based pharmaceuticals company Sun Pharmaceutical Industries Ltd. Auven will receive an upfront payment of USD 40 million plus substantial contingent development and sales milestones with regard to Seciera, Auven's novel patented formulation for the treatment of dry eye disease.